Navigation Links
Research Finds Overdose Deaths Occur When Changing Opioids
Date:3/29/2012

GLENVIEW, Ill., March 29, 2012 /PRNewswire-USNewswire/ -- Common practices for changing from one opioid to another, including use of published dose conversion ratios, may be contributing to the growing number of opioid-related fatalities, new research suggests. The results from a scientific literature review and a case study using this new model of opioid rotation are presented in the April issue of Pain Medicine, the official journal of the American Academy of Pain Medicine (AAPM).

Patients may be rotated from one opioid to another for various reasons, including inadequate pain relief, intolerable side effects or lack of coverage by insurance companies of the original opioid. Opioid rotation has shown to be useful in 50% to 80% of patients. Yet according to a recent report by the U.S. Centers for Disease Control and Prevention (CDC), nearly 15,000 people die every year as a result of overdoses involving prescription opioids. While many decedents were people who took opioids without being prescribed them, some patients do die while under the care of physicians.

"Our goal is to reverse the national trend of unintentional overdose deaths while advocating for appropriate therapy for the one in three Americans who experience chronic pain," said Lynn R. Webster, M.D., study co-investigator and president elect of the AAPM.

Flaws uncovered in the current method of rotating opioids include prescriber error and use of inaccurate dose conversion ratios found in published protocols. Webster, who serves as medical director of Lifetree Clinical Research in Salt Lake City, Utah, completed the study with co-investigator Perry G. Fine, M.D., immediate past president of AAPM and professor of Anesthesiology, Pain Research and Management Centers in the Department of Anesthesiology at the University of Utah.

Concluding that most fatal outcomes during opioid rotation are preventable, the researchers suggested three easy-to-remember steps that eliminate the need to use a conversion table:

1)    Reduce the original opioid dose by 10% to 30% while beginning the new opioid at the lowest available dose.

2)    Reduce the original opioid dose by 10% to 25% per week while increasing the dose of the new daily opioid dose by 10% to 20% based upon clinical need and safety.

3)    Provide sufficient immediate-release opioid throughout the rotation to prevent withdrawal and keep pain levels down so the patient is not tempted to take too much medication.

In most instances, the complete switch can occur within 3 to 4 weeks, which is longer than for most current methods.

More research is needed to prove the new paradigm safe and effective in a broad population of patients. The need for research into optimal therapies was highlighted in a recent report on pain from the Institute of Medicine, which found more than 100 million people in America live with chronic pain.

"It is time for professional societies, government agencies and industry to work together and correct the important flaws in current opioid rotation practices," Webster concluded. "All patients who have indications for opioid therapy must be assured that routine clinical practices are safe and have an evidentiary basis."

View article Review and Critique of Opioid Rotation Practices and Associated Risks of Toxicity…

View article Overdose Deaths Demand a New Paradigm for Opioid Rotation…

About AAPM
The American Academy of Pain Medicine is the premiere association for 2,400 pain physicians and their treatment teams. Now in its 28th year of service, the Academy's mission is to optimize the health of patients in pain and eliminate it as a major public health problem by advancing the practice in the specialty of pain medicine. More information is available at www.painmed.org.

 

 


'/>"/>
SOURCE American Academy of Pain Medicine
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Elsevier Launches New Journal: Journal of Applied Research in Memory and Cognition
2. Life Technologies Launches Ion AmpliSeq™ Custom Panels, Unlocking Thousands of Disease-Related Research Samples for Analysis
3. Clearbridge BioMedics Achieves ISO 13485 Certification and Launches ClearCell (TM) System for Cancer Research Markets
4. Equity Research on Most Popular Searches: Atmel, USG, Applied Materials, Sprint Nextel, Galena Biopharma, and Key Energy Services
5. Frost & Sullivans Advanced Medical Technologies Research Tracks Opportunities in Markets Influenced by Dynamic Care Pathways
6. Nektar Consolidates Research at Its State-of-the-Art R&D Center Located in San Francisco at Mission Bay
7. Awards for Drug Discovery Research for Frontotemporal Degeneration Announced
8. SIRO Clinpharm Announces Appointment of Gopakumar Menon as Chief Executive Officer to Lead the Global Clinical Research Organization
9. Biovista Awarded Research Grant on Chronic Fatigue Syndrome From the CFIDS Association of America
10. EHE International Joins Forces With Entertainment Industry Foundations National Colorectal Cancer Research Alliance and the CDC to Encourage Screening
11. Current Study Offers Window into Automation & Outsourcing Practices Within Top Pharmaceutical Market Research Groups
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/13/2017)... Sept. 13, 2017   OrthoAtlanta has been named ... Football Host Committee (AFHC) for the 2018 College Football Playoff ... 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... AFHC "I,m In" campaign, participating in many activities leading up ... ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., ... Solutions (VLMS), is pleased to announce the appointment ... member of its Board of Directors and Chairman ... VLMS enables life science companies to manage their ... use of paper in this process. Furthermore, ValGenesis ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... September 22, 2017 , ... SABRE ... Scholarship Sweepstakes.,  , Molli C., a graduate student from Sonora, California, who will ... Administration at St. Thomas University in Miami, Florida, was selected from a pool ...
(Date:9/22/2017)... HOUSTON, Texas (PRWEB) , ... September 22, 2017 ... ... leading network of independent freestanding emergency rooms is celebrating the one year anniversary ... anniversary of our facility opening,” said Dr. Otinwa, Facility Medical Director of First ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... products at customers’ doorstep. According to Smart Mart, customers can now order vegetable, ... offer wearable, and customers can find clothing at discounted prices. Apart from this, ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability ... p.m. – 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality ... run afoul of The Quality System Regulation (§820.250), and Devicemakers find themselves staring ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... in their communities, nine governmental public health departments have been awarded five-year accreditation ... decisions mean that the benefits of being served by a PHAB-accredited health ...
Breaking Medicine News(10 mins):